These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10829309)

  • 61. [Tumor heterogeneity. Basal aspects of significance for therapeutic strategy].
    Bjerkvig R
    Tidsskr Nor Laegeforen; 1988 Jan; 108(2):143-6. PubMed ID: 3281316
    [No Abstract]   [Full Text] [Related]  

  • 62. [Cancer research: a privileged field of investigation on chance, reductionism and holism].
    Zielinska A; Issad T
    Med Sci (Paris); 2014; 30(6-7):675-8. PubMed ID: 25014460
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cell injury, retrodifferentiation and the cancer treatment paradox.
    Uriel J
    Tumour Biol; 2015 Sep; 36(10):7365-74. PubMed ID: 26346166
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Studies on inherited cancers: outcomes and challenges of 25 years.
    Brown MA; Solomon E
    Trends Genet; 1997 May; 13(5):202-6. PubMed ID: 9154004
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Manipulating the germline: its impact on the study of carcinogenesis.
    Clarke AR
    Carcinogenesis; 2000 Mar; 21(3):435-41. PubMed ID: 10688863
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cancer genomics.
    Weber BL
    Cancer Cell; 2002 Feb; 1(1):37-47. PubMed ID: 12086886
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The undifferentiated malignant tumor, a continuing challenge.
    Feiner H
    Mod Pathol; 1990 Jan; 3(1):2. PubMed ID: 2308916
    [No Abstract]   [Full Text] [Related]  

  • 68. Klaas Breur Medal lecture 1985. The growth and progression of human tumors: implications for management strategy.
    Tubiana M
    Radiother Oncol; 1986 Jul; 6(3):167-84. PubMed ID: 3529254
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Host genetics influence tumour metastasis.
    Hunter K
    Nat Rev Cancer; 2006 Feb; 6(2):141-6. PubMed ID: 16491073
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Development of a method of combination therapy of malignant tumors at the Gertzen Scientific Research Cancer Institute, Moscow].
    Kiseleva ES; Volkova MA; Dar'ialova SL
    Khirurgiia (Mosk); 1987 Sep; (9):5-9. PubMed ID: 3695253
    [No Abstract]   [Full Text] [Related]  

  • 71. An evolutionary perspective on field cancerization.
    Curtius K; Wright NA; Graham TA
    Nat Rev Cancer; 2018 Jan; 18(1):19-32. PubMed ID: 29217838
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pediatric oncology.
    Davidoff AM
    Semin Pediatr Surg; 2010 Aug; 19(3):225-33. PubMed ID: 20610196
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Cancer occurrence from the biometric viewpoint].
    Abel U
    Fortschr Med; 1986 Feb; 104(8):158-62. PubMed ID: 3957210
    [No Abstract]   [Full Text] [Related]  

  • 74. Neoplasia, ageing, and genetic instability due to defective caretaker genes.
    Hoehn H; Neveling K; Endt D; Melcher R; Schindler D
    Cell Oncol; 2008; 30(5):461-2. PubMed ID: 18791279
    [No Abstract]   [Full Text] [Related]  

  • 75. [Development of malignant neoplasms].
    Tarłowska L
    Pieleg Polozna; 1984; (7):8-10. PubMed ID: 6568724
    [No Abstract]   [Full Text] [Related]  

  • 76. Is there another approach to cancer therapy?--Workshop on suppression of the malignant phenotype.
    Stansly PG
    Cancer Res; 1975 Jun; 35(6):1599-600. PubMed ID: 1131826
    [No Abstract]   [Full Text] [Related]  

  • 77. Cellular and molecular biology of neoplasia. Proceedings of a symposium, Ontario, Canada, October 2-6, 1983.
    J Cell Physiol Suppl; 1984; 3():1-214. PubMed ID: 6589226
    [No Abstract]   [Full Text] [Related]  

  • 78. [Principles and the 1973 draft of the "multistep cancer therapy" with optimal distance after care. Theoretical viewpoints. 2].
    von Ardenne M
    Ther Ggw; 1974 Feb; 113(2):194-8 passim. PubMed ID: 4363579
    [No Abstract]   [Full Text] [Related]  

  • 79. Understanding the biology of cancer: has this any impact on treatment?
    Desai PB
    J Cancer Res Clin Oncol; 1994; 120(4):193-9. PubMed ID: 8288672
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cancer trials. I. Immunologically competent cells in the treatment of malignant disease.
    Nahum LH
    Conn Med; 1968 Aug; 32(8):564. PubMed ID: 5674933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.